Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia A pilot study

Table 1 Demographic and laboratory data (median, range) of patients included in each treatment arm

	Epoetin+Iron (G1, n = 15)	Iron (G2, n = 15)	aP-value
Male/female	10/5	10/5
Age (years)	62, 36-70	58, 35-71	0.54
Ulcer/haemorrhagic gastritis	13/2	12/3
Lost to follow up	1	2
Haematocrit (%)b	29.0, 26.0-33.0	28.8, 26.0-32.5	0.9
Reticulocytes (%)b	3.3, 2.4-3.9	2.8, 2.3-4.2	0.63
Serum iron (μg/dl)b	37, 18-54	38, 24-63	0.37
Ferritin (μg/dl)b	78, 20-147	64, 41-173	0.96
TIBC (μg/dl)b	302, 224-392	302, 250-391	0.92

^aMann-Whitney two-sided U-test,

^bat entry to the study.